eli lilly glp-1 drugs Lilly's oral pill may help people with Type 2 diabetes lose 'significant' weight, study finds Lilly's Double-Beat Widens the GLP-1

doi: 10.1093/brain/awaa262 77 HankeyGJBlackerDJ

The transition toward oral GLP-1 receptor agonists and next-generation multi-receptor therapies presents a significant growth opportunity for market participants by expanding treatment accessibility and improving patient convenience

Increasing water and fiber intake helps manage this

The high demand of GLP-1 drugs has resulted in shortages making it challenging for patients to access the medication through their regular pharmacy

rxlist.com (Byetta ) rxlist.com (Byduron ) extended release formulation Keywords Liraglutide Trade Names: Victoza & generic Pharmacology: GLP-1 analog mechanism of action is the same as exenatide Indications: an adjunct to diet and exercise to improve glycemic control in type 2 diabetes mellitus to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease Pharmacokinetics: once-daily injection Side Effects: Most common : nausea, diarrhea, vomiting (similar to exenatide) Black Box Warning: RISK OF THYROID C-CELL TUMORS References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)